They aimed at establishing whether curcumin influenced the duration of treatment interruption and rate of prostatic specific antigen (PSA) progression, compared with placebo, among men with prostate cancer receiving intermittent androgen deprivation therapy. Here, KLK3 is linked to Familial prostate cancer.